
Current Price | $1.44 | Mkt Cap | $3.4M |
---|---|---|---|
Open | $1.47 | P/E Ratio | 0.00 |
Prev. Close | $1.43 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $1.39 - $1.54 | Volume | 67,027 |
52-Wk Range | $1.20 - $43.00 | Avg. Daily Vol. | 832,526 |
Current Price | $1.44 | Mkt Cap | $3.4M |
---|---|---|---|
Open | $1.47 | P/E Ratio | 0.00 |
Prev. Close | $1.43 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $1.39 - $1.54 | Volume | 67,027 |
52-Wk Range | $1.20 - $43.00 | Avg. Daily Vol. | 832,526 |
Read the most recent pitches from players about EARS.
Recs
Upcoming phase 3 clinical trial to be released as product for tinnitus and sudden hearing loss. This will be a great for people with inner ear disorders and complications.
Recs
Good news for vulture buyers: This Switzerland-based company stated its TACTT2 trial with Keyzilen(TM) for acute inner ear tinnitus missed its primary efficacy endpoints.
Recs
If the trend continues for the week, this is better than I had originally expected. I was thinking 7 by end of the week, but looks 8
Find the members with the highest scoring picks in EARS.
whatsthepoint (99.99) Score: +292.34
The Score Leader is the player with the highest score across all their picks in EARS.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
KingMR012 | < 20 | 10/9/2018 |
![]() |
5Y | $0.60 | +140.00% | +38.13% | +101.87 | 1 Comment | |
sikiliza | < 20 | 7/29/2019 |
![]() |
5Y | $2.81 | -48.75% | +31.37% | +80.12 | 0 Comment | |
IdahoInvestor | 27.53 | 7/25/2019 |
![]() |
5Y | $2.70 | -46.67% | +31.83% | +78.49 | 0 Comment | |
risktech | 21.66 | 4/11/2018 |
![]() |
5Y | $1.37 | +5.11% | +50.52% | +45.41 | 0 Comment | |
Momentum21 | 71.50 | 9/29/2016 |
![]() |
5Y | $1.74 | -17.24% | +83.60% | -100.84 | 0 Comment | |
superstar2 | 98.75 | 8/18/2016 |
![]() |
5Y | $2.21 | -34.84% | +81.37% | -116.21 | 1 Comment | |
roymarshall | 51.97 | 1/6/2016 |
![]() |
3W | $6.10 | -76.39% | +99.94% | -176.34 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.